Literature DB >> 12073603

Primary liposarcoma of the mediastinum.

Takenori Mase1, Nobuhiko Kawawaki, Chihiro Narumiya, Takahiko Aoyama, Shinji Kato, Yoshihisa Nagata.   

Abstract

Primary mediastinal liposarcomas are extremely rare malignancies that remain asymptomatic until large and, even then, initial symptoms are nonspecific. We report a 48-year-old man followed up for asymptomatic multiple bullae who suffered progressive weight loss and dyspnea on exertion. Radiography and computed tomography of the chest showed a large mass with calcified nodules in the left pleural cavity and giant bullae in the right pleural cavity. Previous computed tomography of the chest showed a small tumor of mediastinal adipose tissue with calcified nodules. Tumor growth was calculated at about 500 times the tumor volume per 3.6 years. We completely resected the mediastinal tumor and conducted a bullectomy through a median sternotomy. The microscopic pathological diagnosis was well-differentiated/sclerosing liposarcoma. The man underwent no postoperative adjunctive irradiation and remains well 8 months after surgery.

Entities:  

Mesh:

Year:  2002        PMID: 12073603     DOI: 10.1007/bf03032155

Source DB:  PubMed          Journal:  Jpn J Thorac Cardiovasc Surg        ISSN: 1344-4964


  10 in total

1.  Radiological findings in myxoid liposarcoma of the anterior mediastinum.

Authors:  J I Jung; H Kim; S W Kang; S H Park
Journal:  Br J Radiol       Date:  1998-09       Impact factor: 3.039

2.  Lymphocyte-rich pleural liposarcoma mimicking pericardial cyst.

Authors:  M Iqbal; J Posen; T A Bhuiya; R P Lackner; H N Steinberg; L J Rossoff
Journal:  J Thorac Cardiovasc Surg       Date:  2000-09       Impact factor: 5.209

3.  Successful resection of a primary liposarcoma in the anterior mediastinum in a child: report of a case.

Authors:  M Chiyo; T Fujisawa; T Yasukawa; M Shiba; K Shibuya; Y Sekine; K Hiroshima; H Ohwada
Journal:  Surg Today       Date:  2001       Impact factor: 2.549

4.  Long term survival in non-encapsulated primary liposarcoma of the mediastinum.

Authors:  R G Grewal; K Prager; J H Austin; H Rotterdam
Journal:  Thorax       Date:  1993-12       Impact factor: 9.139

Review 5.  Liposarcoma of the pleural cavity: clinical and pathologic features of 4 cases with a review of the literature.

Authors:  N T Okby; W D Travis
Journal:  Arch Pathol Lab Med       Date:  2000-05       Impact factor: 5.534

Review 6.  [A case of primary anterior mediastinal liposarcoma with a heterotopic mass in the pericardium of the same histology].

Authors:  H Kiyama; S Tanabe; S Nagasawa; Y Irie; N Ohshima; T Yamada
Journal:  Nihon Kyobu Geka Gakkai Zasshi       Date:  1996-12

7.  Liposarcoma of the anterior mediastinum and thymus. A clinicopathologic study of 28 cases.

Authors:  D S Klimstra; C A Moran; G Perino; M N Koss; J Rosai
Journal:  Am J Surg Pathol       Date:  1995-07       Impact factor: 6.394

8.  Long-term survival in a surgically treated non-encapsulated mediastinal primary liposarcoma. Diagnostic utility of core-needle biopsy for mediastinal tumors.

Authors:  R Alvarez-Sala; J Casadevall; P Caballero; C Prados; B Ortega
Journal:  J Cardiovasc Surg (Torino)       Date:  1995-04       Impact factor: 1.888

Review 9.  Pleural liposarcoma presenting with respiratory distress and suspected diaphragmatic hernia.

Authors:  F Carroll; M D Kramer; A J Acinapura; P A Tietjen; I Wagner; S Oiseth; F Smith
Journal:  Ann Thorac Surg       Date:  1992-12       Impact factor: 4.330

Review 10.  Liposarcoma of the pleura.

Authors:  W W Wong; J R Pluth; G L Grado; S E Schild; D R Sanderson
Journal:  Mayo Clin Proc       Date:  1994-09       Impact factor: 7.616

  10 in total
  2 in total

1.  Primary liposarcoma of the heart.

Authors:  Christina Maria Steger
Journal:  BMJ Case Rep       Date:  2011-05-03

2.  [Thymus lipoma. A rare entity of the thymus. Case report with special consideration of diagnostic imaging].

Authors:  B Schlolaut; J Pfannschmidt; E Hecker; H Dienemann; A Schmähl
Journal:  Chirurg       Date:  2004-11       Impact factor: 0.955

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.